Sophie Moullec
Oniris(FR)
Publications by Year
Research Areas
Muscle Physiology and Disorders, Virus-based gene therapy research, Tissue Engineering and Regenerative Medicine, RNA Interference and Gene Delivery, Mesenchymal stem cell research
Most-Cited Works
- → Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy(2017)230 cited
- → Forelimb Treatment in a Large Cohort of Dystrophic Dogs Supports Delivery of a Recombinant AAV for Exon Skipping in Duchenne Patients(2014)114 cited
- → Capsid-specific removal of circulating antibodies to adeno-associated virus vectors(2020)92 cited
- → Vascular Delivery of Allogeneic MuStem Cells in Dystrophic Dogs Requires Only Short-Term Immunosuppression to Avoid Host Immunity and Generate Clinical/Tissue Benefits(2018)15 cited
- → T.P.23 Quantitative evaluation of locoregional high venous pressure rAAV8-U7- ESE6-ESE8 exon-skipping therapy in the GRMD dog using NMR 1H imaging and 31P spectroscopy(2012)3 cited
- → Adeno-associated virus vector (AAV) microdystrophin gene therapy prolongs survival and restores muscle function in the canine model of Duchenne muscular dystrophy (DMD)(2015)3 cited
- → G.P.92(2014)1 cited
- Quantitative NMR 1H imaging and 31P spectroscopy evaluation of locoregional high venous pressure rAAV8-U7-ESE6-ESE8 exon-skipping therapy in the GRMD(2012)
- → 503. Adeno-Associated Virus Vector (AAV) Microdystrophin Gene Therapy Prolongs Survival and Restores Muscle Function in the Canine Model of Duchenne Muscular Dystrophy (DMD)(2016)1 cited
- → Preclinical studies for calpain 3 gene transfer: primate pilot study and dose effect evaluation(2017)